Reporting owner

Russo Rene

Reporting owner CIK 0001722066 · PRESIDENT AND CEO · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

9 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Nov 21, 2025Xilio Therapeutics, Inc.Stock Option (right to buy)Russo ReneStock award
Nov 21, 2025Xilio Therapeutics, Inc.Stock Option (right to buy)Russo ReneStock award
Nov 21, 2025Xilio Therapeutics, Inc.Stock Option (right to buy)Russo ReneStock award
Nov 21, 2025Xilio Therapeutics, Inc.Stock Option (right to buy)Russo ReneStock award
Nov 21, 2025Xilio Therapeutics, Inc.Stock Option (right to buy)Russo ReneStock award
Nov 21, 2025Xilio Therapeutics, Inc.Stock Option (right to buy)Russo ReneStock award
Nov 21, 2025Xilio Therapeutics, Inc.Stock Option (right to buy)Russo ReneStock award
Nov 21, 2025Xilio Therapeutics, Inc.Stock Option (right to buy)Russo ReneStock award
Nov 21, 2025Xilio Therapeutics, Inc.Stock Option (right to buy)Russo ReneStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Xilio Therapeutics, Inc.XLO · company listings
Russo RenePRESIDENT AND CEO · Director
Stock awardStock Option (right to buy)Derivative security · Code A700,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Xilio Therapeutics, Inc.XLO · company listings
Russo RenePRESIDENT AND CEO · Director
Stock awardStock Option (right to buy)Derivative security · Code A350,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Xilio Therapeutics, Inc.XLO · company listings
Russo RenePRESIDENT AND CEO · Director
Stock awardStock Option (right to buy)Derivative security · Code A150,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Xilio Therapeutics, Inc.XLO · company listings
Russo RenePRESIDENT AND CEO · Director
Stock awardStock Option (right to buy)Derivative security · Code A100,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Xilio Therapeutics, Inc.XLO · company listings
Russo RenePRESIDENT AND CEO · Director
Stock awardStock Option (right to buy)Derivative security · Code A50,041Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Xilio Therapeutics, Inc.XLO · company listings
Russo RenePRESIDENT AND CEO · Director
Stock awardStock Option (right to buy)Derivative security · Code A135,134Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Xilio Therapeutics, Inc.XLO · company listings
Russo RenePRESIDENT AND CEO · Director
Stock awardStock Option (right to buy)Derivative security · Code A473,334Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Xilio Therapeutics, Inc.XLO · company listings
Russo RenePRESIDENT AND CEO · Director
Stock awardStock Option (right to buy)Derivative security · Code A239,703Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Xilio Therapeutics, Inc.XLO · company listings
Russo RenePRESIDENT AND CEO · Director
Stock awardStock Option (right to buy)Derivative security · Code A2,075,0000Value: 0Currency not specifiedView ↗